Zentalis Pharmaceuticals to Host a Key Opinion Leader Virtual Meeting to Discuss its Investigational WEE1 Inhibitor ZN-c3 and its Potential as a Best-in-Class Treatment for Advanced Solid Tumors

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

Joey Cohen
Medication Adherence

Liz Kane
Impactful Strategy

Amy Giles
Increasing Engagement

Brenda Snow
Authentic Patient Voice

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Daniel Sontupe
Market Access

Matt Turner
Patient Affordability